Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway.
Chen D, Yu W, Zhong C, Hong Q, Huang G, Que D, Wang Y, Yang Y, Rui B, Zhuang Z, Liang M, Ye Z, Yan X, Lv J, Zhang R, Yan J, Yang P.
Chen D, et al. Among authors: huang g.
Pharmacol Res. 2022 Apr;178:106186. doi: 10.1016/j.phrs.2022.106186. Epub 2022 Mar 17.
Pharmacol Res. 2022.
PMID: 35306141